RCT of Duloxetine and Pregabalin for the Treatment of Gulf War Illness in Veterans

Trial Profile

RCT of Duloxetine and Pregabalin for the Treatment of Gulf War Illness in Veterans

Recruiting
Phase of Trial: Phase II

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Duloxetine (Primary) ; Pregabalin (Primary)
  • Indications Headache; Pain
  • Focus Adverse reactions
  • Acronyms REGIONS
  • Most Recent Events

    • 31 Mar 2017 Planned End Date changed from 1 Jul 2020 to 1 Jan 2021.
    • 31 Mar 2017 Planned primary completion date changed from 1 Jun 2019 to 1 Dec 2019.
    • 29 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top